Search all medical codes
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
CPT4 code
Name of the Procedure:
Influenza Virus Vaccine, Quadrivalent (IIV4), Split Virus, Preservative-Free, 0.5 mL Dosage, for Intramuscular Use
Summary
This procedure involves the administration of a preservative-free quadrivalent influenza vaccine, which helps protect against four strains of the flu virus. The vaccine is given as a 0.5 mL injection into a muscle, typically in the upper arm.
Purpose
- Medical Condition Addressed: Influenza (Flu).
- Goals: To prevent flu infection, reduce the severity of flu symptoms, and decrease the risk of flu-related complications.
Indications
- Specific Symptoms/Conditions: Recommended for individuals aged 6 months and older, particularly those at higher risk for flu complications.
- Patient Criteria: Individuals with chronic health conditions, healthcare workers, pregnant women, and those in close contact with high-risk populations.
Preparation
- Pre-Procedure Instructions: Usually none required; patients should inform healthcare providers of any allergies or current medications.
- Diagnostic Tests/Assessments: Generally, no specific tests are needed before receiving the vaccine.
Procedure Description
- Step-by-Step Explanation:
- The patient is seated, and the upper arm is exposed.
- The injection site is cleaned with an antiseptic wipe.
- A healthcare professional administers a 0.5 mL injection of the vaccine into the deltoid muscle.
- A band-aid is applied to the injection site.
- Tools/Equipment: Syringe, 0.5 mL of preservative-free IIV4 vaccine.
- Anesthesia/Sedation: No anesthesia or sedation is required.
Duration
The injection process typically takes a few minutes, with a 15-minute observation period afterward to monitor for any immediate adverse reactions.
Setting
The procedure is performed in an outpatient setting, such as a doctor's office, clinic, or pharmacy.
Personnel
- Healthcare Professionals Involved: Nurse or physician.
Risks and Complications
- Common Risks: Soreness at the injection site, mild fever, fatigue, muscle aches.
- Rare Risks: Severe allergic reactions (anaphylaxis), Guillain-Barré syndrome.
Benefits
- Expected Benefits: Protection against four strains of the flu, reduction in flu-related complications, and decreased transmission of the flu virus.
- Timeframe: Immunity typically develops within two weeks after vaccination.
Recovery
- Post-Procedure Care: Minimal; patients may take over-the-counter pain relievers for injection site soreness.
- Recovery Time: Immediate return to normal activities; minor soreness or fatigue may last 1-2 days.
- Follow-Up: Annual vaccination is recommended to maintain protection.
Alternatives
- Other Treatment Options: Other types of flu vaccines (e.g., trivalent, live attenuated nasal spray).
- Pros and Cons: Quadrivalent vaccines offer broader protection against more flu strains. Nasal spray vaccines are an alternative for those who fear needles but are not suitable for everyone.
Patient Experience
- During the Procedure: Patients will feel a quick pinch or sting at the injection site.
- After the Procedure: Mild soreness, redness, or swelling at the injection site. Symptoms like low-grade fever or fatigue may occur but are usually brief. Pain can be managed with over-the-counter medications.
Overall, the quadrivalent influenza vaccine is a safe and effective way to protect against the flu and its complications, with minimal discomfort.